CR Labs 獲提名角逐澳洲頂尖醫療科技獎項
CR Labs nominated for top Australian health technology award
先進眼科鏡片技術的領導者 CR Labs，獲選為 2026 年奮進獎 (Endeavour Awards) 中「健康科技創新獎」的決賽入圍者。
CR Labs, a leader in advanced ophthalmic lens technology, has been named a finalist for the prestigious Innovation in Health Technology award at the 2026 Endeavour Awards.
這項認可突顯了該公司在不斷演變的澳洲製造業中所扮演的角色，該產業正日益為全球醫療解決方案做出貢獻。
This recognition highlights their role in the evolving Australian manufacturing sector, which is increasingly contributing to global medical solutions.
奮進獎由《製造商月刊》(Manufacturer’s Monthly) 每年舉辦，旨在表彰卓越與領導力。
Presented annually by Manufacturer’s Monthly, the Endeavour Awards celebrate excellence and leadership.
在「健康科技創新」類別中，CR Labs 面臨來自包含 Cochlear Ltd 與 Optiscan Imaging Ltd 在內等九家創新企業的競爭。
In the Innovation in Health Technology category, CR Labs faces competition from nine other innovative companies, including Cochlear Ltd and Optiscan Imaging Ltd.
執行長 Adam Fletcher 與商務長 Todd Spencer 正帶領 CR Labs 團隊等待最終結果揭曉。
CEO Adam Fletcher and CCO Todd Spencer are leading the charge for CR Labs as they await the final announcement.
獲獎者將於 2026 年 5 月 13 日在布里斯本威斯汀酒店 (The Westin Brisbane) 舉行的盛大晚宴上公佈。
The winners will be revealed during a gala dinner at The Westin Brisbane on May 13, 2026.
此提名反映了澳洲國內製造業在開發尖端診斷工具方面日益提升的實力與全球重要性。
This nomination reflects the strength and rising global importance of Australia's domestic manufacturing industry in developing cutting-edge diagnostic tools.
這對團隊而言是一個令人振奮的里程碑，也凸顯了他們致力於醫療創新的承諾。
It is an exciting milestone for the team, underscoring their commitment to medical innovation.
